Does vitamin D influence hepatitis B surface antibodies in non-vaccinated patients on hemodialysis?

Nefrologia (Engl Ed). 2019 Jul-Aug;39(4):442-443. doi: 10.1016/j.nefro.2018.11.004. Epub 2019 Feb 16.

[Article in English, Spanish]

Authors

Mercedes Arruche¹, Javier Varas², Abraham Rincón², Rosa Ramos², Darío Moreno³, Carmen Cabré⁴

Affiliations

¹ Fresenius Medical Care, Reus, España. Electronic address: marrucheh@senefro.org.
² Fresenius Medical Care, Madrid, España.
³ Fresenius Medical Care, Aranda de Duero, España.
⁴ Nefrología-Hemodiálisis, Clínica Fuensanta, Madrid, España.

PMID: 30782499
DOI: 10.1016/j.nefro.2018.11.004

No abstract available

Publication types

Letter
Observational Study

MeSH terms

Hepatitis B Antibodies / drug effects*
Hepatitis B Antibodies / immunology
Hepatitis B Surface Antigens / immunology
Hepatitis B Vaccines
Humans
Renal Dialysis*
Retrospective Studies
Vitamin D / pharmacology*

Substances

Hepatitis B Antibodies
Hepatitis B Surface Antigens
Hepatitis B Vaccines
Vitamin D